What is SS Innovations's earnings per share (EPS)?

SS Innovations (SSII) reported diluted earnings per share of -$0.06 for fiscal year 2025. This represents a 45.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SS Innovations Financials

SSII

FY2025 annual

Revenue $42.5M +105.7% YoY

Net Income -$12.1M +36.7% YoY

EPS (Diluted) -$0.06 +45.5% YoY

Free Cash Flow -$22.2M -118.4% YoY

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

SS Innovations (SSII) reported $42.5M in revenue for fiscal year 2025, up 105.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SSII FY2025 2026-08-13

Margin recovery is real, but growth is soaking up cash in inventory and receivables faster than operations can replenish it.

Recent revenue scaling lifted gross margin to 46.0% and cut the operating margin loss to -19.3%, so the basic sale is becoming far less uneconomic. But that improvement did not reach cash: inventory plus receivables absorbed about $14.8M, helping keep operating cash flow at -$18.5M.

Gross profit now nearly covers core overhead: $19.5M of gross profit against $18.5M of SG&A plus R&D. That changes the operating question from product-level economics to whether growth and working capital can be financed without straining liquidity in practice.

The balance sheet looks less stretched than a year earlier, with liabilities below equity and a current ratio of 1.9x. Yet cash of $3.2M was far smaller than financing inflows of $26.2M, which implies recent expansion still depended on outside capital for both operations and investment.

Financial Health Signals

Financial Health Score 40/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SS Innovations's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Safe

11.44

SS Innovations scores 11.44, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($715.4M) relative to total liabilities ($36.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

SS Innovations passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

SS Innovations reported a net loss of $12.1M while operations used $18.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

SS Innovations reported an operating loss of $8.2M against $272K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$42.5M

YoY+105.7%

SS Innovations generated $42.5M in revenue in fiscal year 2025. This represents an increase of 105.7% from the prior year.

EBITDA

-$7.1M

YoY+61.6%

SS Innovations's EBITDA was -$7.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 61.6% from the prior year.

Net Income

-$12.1M

YoY+36.7%

SS Innovations reported -$12.1M in net income in fiscal year 2025. This represents an increase of 36.7% from the prior year.

EPS (Diluted)

-$0.06

YoY+45.5%

SS Innovations earned -$0.06 per diluted share (EPS) in fiscal year 2025. This represents an increase of 45.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$22.2M

YoY-118.4%

SS Innovations recorded an outflow of $22.2M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 118.4% from the prior year.

Cash & Debt

$3.2M

YoY+587.3%

5Y CAGR+82.0%

SS Innovations held $3.2M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

194M

YoY+13.6%

SS Innovations had 194M shares outstanding in fiscal year 2025. This represents an increase of 13.6% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

46.0%

YoY+5.1pp

SS Innovations's gross margin was 46.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 5.1 percentage points from the prior year.

Operating Margin

-19.3%

YoY+72.6pp

SS Innovations's operating margin was -19.3% in fiscal year 2025, reflecting core business profitability. This is up 72.6 percentage points from the prior year.

Net Margin

-28.5%

YoY+64.2pp

SS Innovations's net profit margin was -28.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 64.2 percentage points from the prior year.

Return on Equity

-31.7%

YoY+110.6pp

SS Innovations's ROE was -31.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 110.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$3.7M

YoY+47.9%

5Y CAGR+314.8%

SS Innovations invested $3.7M in research and development in fiscal year 2025. This represents an increase of 47.9% from the prior year.

Capital Expenditures

$3.7M

YoY+453.2%

SS Innovations invested $3.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 453.2% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

SSII Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SSII annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Revenue	$52.4M	$42.5M+105.7%	$20.6M+251.5%	$5.9M+309.1%	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$27.4M	$22.9M+88.1%	$12.2M+136.8%	$5.1M+274.4%	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$25.0M	$19.5M+131.2%	$8.5M+1065.0%	$726K+1097.7%	$61K	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$5.6M	$3.7M+47.9%	$2.5M+135.4%	$1.1M+7.2%	$987K+98644.3%	$1K-66.7%	$3K-95.1%	$61K+124.4%	$27K-61.9%	$71K-44.2%	$128K
SG&A Expenses	$17.0M	$14.8M+46.2%	$10.2M+0.9%	$10.1M+420.1%	$1.9M+321.8%	$459K+59.5%	$288K	N/A	$404K-57.0%	$940K+180.6%	$335K
Operating Income	-$8.3M	-$8.2M+56.8%	-$19.0M+6.4%	-$20.3M-585.3%	-$3.0M	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$288K	$272K-14.4%	$317K-39.4%	$523K+223.1%	$162K	N/A	$1K-94.6%	$20K	N/A	$27K+19.9%	$23K
Income Tax	N/A	$4.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$12.4M	-$12.1M+36.7%	-$19.2M+8.3%	-$20.9M-549.6%	-$3.2M-116.5%	-$1.5M-32.0%	-$1.1M	N/A	N/A	-$1.0M-114.0%	-$485K
EPS (Diluted)	—	-$0.06+45.5%	-$0.11+21.4%	-$0.14-366.7%	-$0.03	-$0.050.0%	-$0.05+68.8%	-$0.16	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$13.9M+25.6%	$11.1M-23.6%	$14.5M+13.3%	$12.8M+28.3%	$10.0M+95.3%	$5.1M-36.9%	$8.1M+85.0%	$4.4M
Cost of Revenue	$6.8M+18.4%	$5.8M-29.2%	$8.2M+22.4%	$6.7M+63.1%	$4.1M+1.3%	$4.0M-2.7%	$4.1M+100.4%	$2.1M
Gross Profit	$7.1M+33.3%	$5.3M-16.5%	$6.4M+3.4%	$6.2M+4.2%	$5.9M+444.1%	$1.1M-72.6%	$4.0M+71.3%	$2.3M
R&D Expenses	$2.4M+140.7%	$995K-28.4%	$1.4M+76.9%	$786K+57.7%	$499K-50.6%	$1.0M+32.6%	$762K+72.1%	$443K
SG&A Expenses	$4.5M-1.1%	$4.5M+41.3%	$3.2M-33.9%	$4.8M+40.6%	$3.4M+0.5%	$3.4M+33.2%	$2.6M+2.1%	$2.5M
Operating Income	-$2.3M+37.6%	-$3.6M-581.5%	-$534K+70.9%	-$1.8M-1991.8%	$97K+101.6%	-$5.9M-222.1%	-$1.8M+42.6%	-$3.2M
Interest Expense	$345K+691.6%	$44K+115.7%	-$277K-256.7%	$177K-18.5%	$217K+39.9%	$155K+143.5%	-$356K-243.8%	$248K
Income Tax	$505K+233.8%	$151K	N/A	$1.8M+422.2%	$354K	N/A	N/A	N/A
Net Income	-$2.7M+25.7%	-$3.6M-45.0%	-$2.5M+33.5%	-$3.7M-1348.4%	-$257K+95.5%	-$5.7M-195.4%	-$1.9M+40.7%	-$3.2M
EPS (Diluted)	-$0.01+50.0%	-$0.02	N/A	-$0.02	$0.00+100.0%	-$0.03	N/A	-$0.02

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SSII Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SSII annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Total Assets	$74.2M+75.1%	$42.4M+34.5%	$31.5M+351.5%	$7.0M+1528.7%	$429K+34.8%	$318K+139.9%	$133K-8.9%	$145K-71.5%	$510K+74.5%	$292K
Current Assets	$48.8M+77.9%	$27.4M+27.9%	$21.4M+423.3%	$4.1M+903.6%	$408K+150.3%	$163K+368.9%	$35K-16.3%	$42K-91.0%	$463K+86.2%	$249K
Cash & Equivalents	$3.2M+587.3%	$467K-76.9%	$2.0M+831.2%	$217K-46.5%	$406K+152.5%	$161K+464.4%	$28K-20.3%	$36K-92.1%	$453K+82.3%	$248K
Inventory	$17.1M+67.2%	$10.2M+45.4%	$7.0M+676.2%	$904K	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$12.4M+177.6%	$4.5M+134.9%	$1.9M+1112.1%	$157K	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$36.0M+24.5%	$28.9M+145.2%	$11.8M+22.1%	$9.7M+6252.1%	-$157K-113.2%	$1.2M-0.7%	$1.2M+224.5%	$368K-9.9%	$409K-36.8%	$647K
Current Liabilities	$26.2M+23.0%	$21.3M+151.7%	$8.5M+9.1%	$7.8M+2603.3%	$287K-75.8%	$1.2M-0.7%	$1.2M+224.5%	$368K-9.9%	$409K-36.8%	$647K
Long-Term Debt	N/A	N/A	$510K+8.8%	$469K	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$38.2M+184.0%	$13.5M-31.8%	$19.7M+836.2%	-$2.7M-557.4%	$586K+167.4%	-$869K+18.3%	-$1.1M-376.7%	-$223K-320.6%	$101K+128.5%	-$355K
Retained Earnings	-$55.8M-27.8%	-$43.7M-78.1%	-$24.5M-574.7%	-$3.6M+57.1%	-$8.5M-21.2%	-$7.0M-19.2%	-$5.9M-136.4%	-$2.5M-63.1%	-$1.5M-213.9%	-$485K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$97.0M+7.1%	$90.5M+22.0%	$74.2M+6.7%	$69.6M-0.6%	$70.0M+10.3%	$63.5M+49.7%	$42.4M+8.6%	$39.0M
Current Assets	$71.5M+7.8%	$66.3M+35.9%	$48.8M+0.7%	$48.4M-4.7%	$50.8M+6.6%	$47.6M+73.7%	$27.4M+9.3%	$25.1M
Cash & Equivalents	$13.6M-14.6%	$16.0M+398.4%	$3.2M-43.6%	$5.7M-50.1%	$11.4M-28.3%	$15.9M+3302.6%	$467K+111.7%	$220K
Inventory	$18.5M+8.3%	$17.1M0.0%	$17.1M-14.8%	$20.0M+9.7%	$18.3M+27.7%	$14.3M+40.1%	$10.2M+8.3%	$9.4M
Accounts Receivable	$17.0M+20.9%	$14.1M+13.4%	$12.4M+79.2%	$6.9M+15.8%	$6.0M+50.8%	$4.0M-11.3%	$4.5M+14.1%	$3.9M
Total Liabilities	$43.6M+21.0%	$36.0M0.0%	$36.0M+20.3%	$29.9M+7.1%	$28.0M+22.1%	$22.9M-20.8%	$28.9M+14.2%	$25.3M
Current Liabilities	$31.9M+22.4%	$26.0M-0.7%	$26.2M+23.9%	$21.2M+8.0%	$19.6M+30.8%	$15.0M-29.7%	$21.3M+15.3%	$18.5M
Total Equity	$53.4M-2.1%	$54.5M+42.7%	$38.2M-3.6%	$39.6M-5.6%	$42.0M+3.6%	$40.6M+201.4%	$13.5M-1.7%	$13.7M
Retained Earnings	-$62.0M-4.5%	-$59.4M-6.4%	-$55.8M-4.6%	-$53.3M-7.5%	-$49.6M-0.5%	-$49.3M-13.0%	-$43.7M-4.6%	-$41.7M

Not reported in any period shown, so not listed: Goodwill.

SSII Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SSII annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Operating Cash Flow	-$15.5M	-$18.5M-95.1%	-$9.5M+38.1%	-$15.4M-156.3%	-$6.0M-1551.2%	-$363K-301.0%	-$91K+78.7%	-$424K+4.3%	-$443K+0.8%	-$447K-110.8%	-$212K
Capital Expenditures	N/A	$3.7M+453.2%	$661K+45.9%	$453K+105.8%	$220K	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$22.2M-118.4%	-$10.2M+35.7%	-$15.8M-154.5%	-$6.2M	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.7M	-$3.7M-453.2%	-$661K-45.9%	-$453K-288.2%	$241K+531.2%	$38K+186.7%	-$44K+12.2%	-$50K-112.7%	-$24K-464.6%	-$4K	N/A
Financing Cash Flow	$26.1M	$26.2M+177.6%	$9.4M-58.7%	$22.8M+286.6%	$5.9M+934.5%	$570K+113.6%	$267K-42.9%	$467K+834.0%	$50K-92.4%	$655K	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$26K	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$4.2M-83.2%	-$2.3M-52.1%	-$1.5M+79.7%	-$7.5M-116.3%	-$3.5M+43.4%	-$6.1M-87.1%	-$3.3M-28.1%	-$2.5M
Capital Expenditures	N/A	$54K-96.8%	$1.7M+127.1%	$755K+138.5%	$317K-63.7%	$873K+597.5%	$125K-92.7%	-$1.7M
Free Cash Flow	N/A	-$2.4M+26.8%	-$3.2M+60.7%	-$8.2M-118.2%	-$3.8M+46.0%	-$7.0M-106.0%	-$3.4M+20.3%	-$4.2M
Investing Cash Flow	-$161K-196.9%	-$54K+96.8%	-$1.7M-127.1%	-$755K-138.5%	-$317K+63.7%	-$873K-597.5%	-$125K-107.3%	$1.7M
Financing Cash Flow	$3.5M-80.8%	$18.2M+1222.5%	$1.4M-55.6%	$3.1M+540.0%	-$702K-103.1%	$22.4M+556.9%	$3.4M+372.2%	$722K

Not reported in any period shown, so not listed: Dividends Paid.

SSII Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SSII annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Gross Margin	46.0%+5.1pp	40.9%+28.6pp	12.3%+8.1pp	4.2%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-19.3%+72.6pp	-91.9%	-345.1%	-206.0%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-28.5%+64.2pp	-92.7%	-355.4%	-223.8%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-31.7%+110.6pp	-142.3%-36.4pp	-105.9%	N/A	-253.5%	N/A	N/A	N/A	-1026.5%	N/A
Return on Assets	-16.3%+28.8pp	-45.2%+21.1pp	-66.3%-20.2pp	-46.0%+300.3pp	-346.3%+7.5pp	-353.8%	N/A	N/A	-203.5%-37.5pp	-166.0%
Current Ratio	1.86+0.6x	1.29-1.2x	2.53+2.0x	0.53-0.9x	1.42+1.3x	0.14+0.1x	0.03-0.1x	0.11-1.0x	1.13+0.7x	0.38
Debt-to-Equity	0.94-1.2x	2.15+2.1x	0.03	N/A	N/A	N/A	N/A	N/A	4.04	N/A
FCF Margin	-52.3%-3.0pp	-49.2%	-269.2%	-432.7%	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	50.9%+2.9pp	48.0%+4.1pp	43.9%-4.2pp	48.0%-11.1pp	59.2%+37.9pp	21.2%-27.7pp	48.9%-3.9pp	52.8%
Operating Margin	-16.3%+16.5pp	-32.8%-29.1pp	-3.7%+10.6pp	-14.3%-15.3pp	1.0%	-115.7%	-22.7%+50.4pp	-73.1%
Net Margin	-19.1%+13.2pp	-32.3%-15.3pp	-17.0%+12.0pp	-29.0%-26.4pp	-2.6%	-110.9%	-23.7%+50.3pp	-74.0%
Return on Equity	-5.0%+1.6pp	-6.6%-0.1pp	-6.5%+2.9pp	-9.4%-8.8pp	-0.6%+13.4pp	-14.0%+0.3pp	-14.3%+9.4pp	-23.7%
Return on Assets	-2.7%+1.2pp	-4.0%-0.6pp	-3.3%+2.0pp	-5.3%-5.0pp	-0.4%+8.6pp	-8.9%-4.4pp	-4.5%+3.8pp	-8.3%
Current Ratio	2.24-0.3x	2.54+0.7x	1.86-0.4x	2.29-0.3x	2.59-0.6x	3.18+1.9x	1.29-0.1x	1.36
Debt-to-Equity	0.82+0.2x	0.66-0.3x	0.94+0.2x	0.75+0.1x	0.67+0.1x	0.56-1.6x	2.15+0.3x	1.85
FCF Margin	N/A	-21.3%+0.9pp	-22.3%+41.8pp	-64.1%-26.4pp	-37.7%	-136.2%	-41.7%+55.1pp	-96.9%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Integra Lifesciences Hldgs Cp IART

$1.3B

Adapthealth Corp AHCO

$731.1M

Novocure NVCR

$2.1B

Beta Bionics, Inc. BBNX

$870.1M

Establishment Labs Hldgs Inc ESTA

$2.2B

Where SS Innovations Ranks

Frequently Asked Questions

What is SS Innovations's annual revenue?

SS Innovations (SSII) reported $42.5M in total revenue for fiscal year 2025. This represents a 105.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SS Innovations's revenue growing?

SS Innovations (SSII) revenue grew by 105.7% year-over-year, from $20.6M to $42.5M in fiscal year 2025.

Is SS Innovations profitable?

No, SS Innovations (SSII) reported a net income of -$12.1M in fiscal year 2025, with a net profit margin of -28.5%.

What is SS Innovations's EBITDA?

SS Innovations (SSII) had EBITDA of -$7.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is SS Innovations's gross margin?

SS Innovations (SSII) had a gross margin of 46.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is SS Innovations's operating margin?

SS Innovations (SSII) had an operating margin of -19.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is SS Innovations's net profit margin?

SS Innovations (SSII) had a net profit margin of -28.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is SS Innovations's return on equity (ROE)?

SS Innovations (SSII) has a return on equity of -31.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is SS Innovations's free cash flow?

SS Innovations (SSII) recorded an outflow of $22.2M in free cash flow during fiscal year 2025. This represents a -118.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is SS Innovations's operating cash flow?

SS Innovations (SSII) recorded an outflow of $18.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are SS Innovations's total assets?

SS Innovations (SSII) had $74.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are SS Innovations's capital expenditures?

SS Innovations (SSII) invested $3.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does SS Innovations spend on research and development?

SS Innovations (SSII) invested $3.7M in research and development during fiscal year 2025.

How many shares does SS Innovations have outstanding?

SS Innovations (SSII) had 194M shares outstanding as of fiscal year 2025.

What is SS Innovations's current ratio?

SS Innovations (SSII) had a current ratio of 1.86 as of fiscal year 2025, which is generally considered healthy.

What is SS Innovations's debt-to-equity ratio?

SS Innovations (SSII) had a debt-to-equity ratio of 0.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is SS Innovations's return on assets (ROA)?

SS Innovations (SSII) had a return on assets of -16.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does SS Innovations's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, SS Innovations (SSII) held $3.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $18.5M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is SS Innovations's Altman Z-Score?

SS Innovations (SSII) has an Altman Z-Score of 11.44, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is SS Innovations's Piotroski F-Score?

SS Innovations (SSII) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are SS Innovations's earnings high quality?

SS Innovations (SSII) reported a net loss of $12.1M while operations used $18.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can SS Innovations cover its interest payments?

SS Innovations (SSII) reported an operating loss of $8.2M against $272K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is SS Innovations?

SS Innovations (SSII) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.